back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-10-10 13:22 Tx date 2025-10-10 |
$FRX
Fennec Pharmaceuticals Inc. |
Rallis, Chris Anigeron
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-16,401
-1,775 vol $9.24 each |
55,316 | |
| Filed 2025-10-10 13:21 Tx date 2025-10-10 |
$FRX
Fennec Pharmaceuticals Inc. |
Rallis, Chris Anigeron
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,996
+4,062 vol $1.23 each |
57,091 | |
| Filed 2025-10-10 13:20 Tx date 2025-10-10 |
$FRX
Fennec Pharmaceuticals Inc. |
Rallis, Chris Anigeron
4 - Director of Issuer
Direct Ownership
|
Options
10 - Acquisition or disposition in the public market
|
$-4,996.26
-4,062 vol $1.23 each |
226,573 | |
| Filed 2025-07-08 09:09 Tx date 2025-07-07 |
$FRX
Fennec Pharmaceuticals Inc. |
Rallis, Chris Anigeron
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-9,746.49
-1,119 vol $8.71 each |
53,029 | |
| Filed 2025-07-08 09:08 Tx date 2025-07-07 |
$FRX
Fennec Pharmaceuticals Inc. |
Rallis, Chris Anigeron
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,998
+2,127 vol $2.35 each |
54,148 | |
| Filed 2025-07-08 09:06 Tx date 2025-07-07 |
$FRX
Fennec Pharmaceuticals Inc. |
Rallis, Chris Anigeron
4 - Director of Issuer
Direct Ownership
|
Options
10 - Acquisition or disposition in the public market
|
$-4,998.45
-2,127 vol $2.35 each |
230,635 | |
| Filed 2025-06-05 12:43 Tx date 2025-06-03 |
$FRX
Fennec Pharmaceuticals Inc. |
Rallis, Chris Anigeron
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$157,600
+20,000 vol $7.88 each |
232,762 | |
| Filed 2025-04-11 16:09 Tx date 2025-04-11 |
$FRX
Fennec Pharmaceuticals Inc. |
Rallis, Chris Anigeron
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-6,974.55
-1,409 vol $4.95 each |
52,021 | |
| Filed 2025-04-11 16:08 Tx date 2025-04-11 |
$FRX
Fennec Pharmaceuticals Inc. |
Rallis, Chris Anigeron
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,997
+2,173 vol $2.30 each |
53,430 | |
| Filed 2025-04-11 16:07 Tx date 2025-04-11 |
$FRX
Fennec Pharmaceuticals Inc. |
Rallis, Chris Anigeron
4 - Director of Issuer
Direct Ownership
|
Options
10 - Acquisition or disposition in the public market
|
$-4,997.90
-2,173 vol $2.30 each |
212,762 | |
| Filed 2025-02-14 17:00 Tx date 2025-02-14 |
$FRX
Fennec Pharmaceuticals Inc. |
Rallis, Chris Anigeron
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-8,088.52
-1,186 vol $6.82 each |
51,257 | |
| Filed 2025-02-14 17:00 Tx date 2025-02-14 |
$FRX
Fennec Pharmaceuticals Inc. |
Rallis, Chris Anigeron
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$499,992
+1,992 vol $251.00 each |
52,443 | |
| Filed 2025-02-14 16:59 Tx date 2025-02-14 |
$FRX
Fennec Pharmaceuticals Inc. |
Rallis, Chris Anigeron
4 - Director of Issuer
Direct Ownership
|
Options
10 - Acquisition or disposition in the public market
|
$-4,999.92
-1,992 vol $2.51 each |
214,935 | |
| Filed 2024-10-08 17:15 Tx date 2024-10-08 |
$FRX
Fennec Pharmaceuticals Inc. |
Rallis, Chris Anigeron
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-6,369.18
-1,406 vol $4.53 each |
50,451 | |
| Filed 2024-10-08 17:15 Tx date 2024-10-08 |
$FRX
Fennec Pharmaceuticals Inc. |
Rallis, Chris Anigeron
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,998
+1,960 vol $2.55 each |
51,857 | |
| Filed 2024-10-08 17:13 Tx date 2024-10-08 |
$FRX
Fennec Pharmaceuticals Inc. |
Rallis, Chris Anigeron
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-4,998
-1,960 vol $2.55 each |
216,927 | |
| Filed 2024-08-19 16:17 Tx date 2024-08-15 |
$FRX
Fennec Pharmaceuticals Inc. |
Rallis, Chris Anigeron
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$111,600
+20,000 vol $5.58 each |
218,887 | |
| Filed 2024-07-08 14:11 Tx date 2024-07-05 |
$FRX
Fennec Pharmaceuticals Inc. |
Rallis, Chris Anigeron
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-7,073.19
-1,173 vol $6.03 each |
49,897 | |
| Filed 2024-07-08 14:09 Tx date 2024-07-05 |
$FRX
Fennec Pharmaceuticals Inc. |
Rallis, Chris Anigeron
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-4,999.68
-1,792 vol $2.79 each |
198,887 | |
| Filed 2024-07-08 14:08 Tx date 2024-07-05 |
$FRX
Fennec Pharmaceuticals Inc. |
Rallis, Chris Anigeron
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,999
+1,792 vol $2.79 each |
51,070 |